Global Monoclonal Antibody Partnering Terms and Agreements Report 2021: Trends in Monoclonal Antibodies Dealmaking in the Biopharma industry Since 2014
June 09, 2021 06:53 ET | Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021" report has been added to ResearchAndMarkets.com's offering. The Global...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)
May 25, 2021 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Emergen logo.png
Research Antibodies Market Size to Reach USD 5,325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem Cells will Drive the Industry Growth, says Emergen Research
March 04, 2021 17:00 ET | Emergen Research
Vancouver, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- The global research antibodies market is projected to acquire up to USD 5,325.8 Million by 2027, registering a CAGR of 5.9% over the...
Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China
January 06, 2020 07:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics (Nasdaq: SRNE) announced today that its partner Mabpharm (HK:2181) filed recently a New Drug Application for the Infliximab...
Global and Chinese Monoclonal Antibody Industry Report, 2013
October 21, 2013 11:26 ET | Research and Markets
Dublin, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/nx5lzf/global_and) has announced the addition of the "Global and Chinese Monoclonal Antibody...